Campbell & Co Investment Adviser’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-26,693
Closed -$3.45M 1188
2026
Q1
$3.45M Buy
26,693
+7,218
+37% +$1.04M 0.2% 144
2025
Q4
$2.78M Buy
+19,475
New +$2.61M 0.13% 233
2025
Q3
Sell
-5,477
Closed -$724K 1234
2025
Q2
$724K Buy
5,477
+2,336
+74% +$317K 0.05% 643
2025
Q1
$436K Sell
3,141
-31,983
-91% -$4.96M 0.03% 740
2024
Q4
$5.45M Buy
+35,124
New +$5.94M 0.42% 37
2024
Q2
Sell
-11,822
Closed -$1.27M 1172
2024
Q1
$1.27M Buy
11,822
+7,888
+201% +$784K 0.11% 301
2023
Q4
$392K Sell
3,934
-8,736
-69% -$854K 0.04% 816
2023
Q3
$1.51M Buy
12,670
+7,580
+149% +$1.13M 0.18% 154
2023
Q2
$907K Sell
5,090
-3,310
-39% -$607K 0.16% 189
2023
Q1
$1.39M Buy
8,400
+4,034
+92% +$694K 0.26% 77
2022
Q4
$688K Buy
+4,366
New +$664K 0.16% 194
2022
Q3
Sell
-2,987
Closed -$491K 799
2022
Q2
$491K Buy
2,987
+739
+33% +$142K 0.13% 276
2022
Q1
$500K Buy
+2,248
New +$504K 0.13% 277
2021
Q4
Sell
-4,450
Closed -$1.04M 703
2021
Q3
$1.04M Buy
+4,450
New +$933K 0.34% 59
2020
Q4
Sell
-2,600
Closed -$475K 488
2020
Q3
$475K Buy
2,600
+476
+22% +$89.6K 0.35% 80
2020
Q2
$391K Buy
+2,124
New +$422K 0.49% 52
2019
Q2
Sell
-4,626
Closed -$1.11M 604
2019
Q1
$1.11M Buy
+4,626
New +$1.11M 0.54% 15
2018
Q4
Sell
-1,483
Closed -$419K 404
2018
Q3
$419K Buy
1,483
+700
+89% +$205K 0.28% 115
2018
Q2
$230K Buy
+783
New +$214K 0.18% 269
2015
Q4
Sell
-1,948
Closed -$213K 147
2015
Q3
$213K Buy
+1,948
New +$208K 0.14% 260
2013
Q4
Sell
-21,943
Closed -$1.49M 264
2013
Q3
$1.49M Buy
+21,943
New +$1.57M 0.29% 106

Other funds holding ICUI

Campbell & Co Investment Adviser's ICUI Position: Q2 2026 in Review

Campbell & Co Investment Adviser sold out of ICU Medical (ICUI) in Q2 2026, closing a stake of 26,693 shares — an estimated $3.45M sold.

Campbell & Co Investment Adviser first reported a position in ICUI in Q3 2013 and held it in 21 quarters. The position peaked at $5.45M in Q4 2024. 118 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

  • Campbell & Co Investment Adviser reported no remaining ICU Medical position as of Q2 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 26,693 ICU Medical shares in Q2 2026, an estimated $3.45M.
  • Campbell & Co Investment Adviser first reported a position in ICU Medical in Q3 2013 and held it in 21 quarters.
  • Campbell & Co Investment Adviser's ICU Medical position peaked at $5.45M in Q4 2024.
  • 118 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.